• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.序列特异性转录因子p53的功能突变体及其对多样性主控基因的影响。
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9934-9. doi: 10.1073/pnas.1633803100. Epub 2003 Aug 8.
2
Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.对酵母有毒性的新型人类p53突变可增强特定启动子的反式激活作用并重新激活肿瘤p53突变体。
Oncogene. 2001 Jun 7;20(26):3409-19. doi: 10.1038/sj.onc.1204457.
3
Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.p53转录因子的差异反式激活高度依赖于p53水平和启动子靶序列。
Mol Cell Biol. 2002 Dec;22(24):8612-25. doi: 10.1128/MCB.22.24.8612-8625.2002.
4
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.非经典DNA基序作为野生型和突变型p53的反式激活靶标。
PLoS Genet. 2008 Jun 27;4(6):e1000104. doi: 10.1371/journal.pgen.1000104.
5
Functional evolution of the p53 regulatory network through its target response elements.p53调控网络通过其靶标反应元件的功能进化。
Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):944-9. doi: 10.1073/pnas.0704694105. Epub 2008 Jan 10.
6
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes.人类主要调控因子p53的生物学影响可因改变其靶基因谱和表达的突变而发生改变。
Mol Cell Biol. 2006 Mar;26(6):2297-308. doi: 10.1128/MCB.26.6.2297-2308.2006.
7
Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.通过基于酵母的功能测定法观察p53反式激活特异性的演变
PLoS One. 2015 Feb 10;10(2):e0116177. doi: 10.1371/journal.pone.0116177. eCollection 2015.
8
p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay.利用一种灵敏的基于酵母的功能分析方法,发现了具有增强转录激活作用和改变启动子选择性的p53突变体。
Oncogene. 2001 Jan 25;20(4):501-13. doi: 10.1038/sj.onc.1204116.
9
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.p53突变体通常能够反式激活含有p21反应元件的启动子,但不能激活含有Bax或PIG3反应元件的启动子。
Oncogene. 2001 Jun 14;20(27):3573-9. doi: 10.1038/sj.onc.1204468.
10
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.在乳腺癌中发现的具有功能改变的 p53 错义突变可以对反式激活产生细微影响。
Mol Cancer Res. 2010 May;8(5):701-16. doi: 10.1158/1541-7786.MCR-09-0442. Epub 2010 Apr 20.

引用本文的文献

1
Epstein-Barr virus replication within differentiated epithelia requires pRb sequestration of activator E2F transcription factors. Epstein-Barr 病毒在分化上皮细胞内的复制需要 pRb 将激活剂 E2F 转录因子隔离。
J Virol. 2024 Oct 22;98(10):e0099524. doi: 10.1128/jvi.00995-24. Epub 2024 Sep 18.
2
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions.近期关于突变型 p53 的研究进展:揭示新的致癌作用、降解途径和治疗干预措施。
Biomolecules. 2024 May 31;14(6):649. doi: 10.3390/biom14060649.
3
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.p53 调控的细胞命运:癌症治疗中的朋友还是可逆的敌人?
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
4
Mutation in Acute Myeloid Leukemia: An Old Foe Revisited.急性髓系白血病中的突变:旧敌新探
Cancers (Basel). 2023 Sep 30;15(19):4816. doi: 10.3390/cancers15194816.
5
Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5-mediated p53 degradation blockage.通过 PDCD5 介导的 p53 降解阻断作用,新型转录本 LNPPS 作为膀胱癌肿瘤抑制因子的特征。
Clin Transl Med. 2023 Jan;13(1):e1149. doi: 10.1002/ctm2.1149.
6
Mutant p53 expression enables a partial capacity to modulate metabolism.突变型p53的表达使细胞具备部分调节代谢的能力。
Front Genet. 2022 Sep 26;13:974662. doi: 10.3389/fgene.2022.974662. eCollection 2022.
7
Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule.小分子对p53/MDM2和p53/MDM4双重抑制的新型变构机制
Front Mol Biosci. 2022 Jun 1;9:823195. doi: 10.3389/fmolb.2022.823195. eCollection 2022.
8
p66α Suppresses Breast Cancer Cell Growth and Migration by Acting as Co-Activator of p53.p66α 通过作为 p53 的共激活因子来抑制乳腺癌细胞的生长和迁移。
Cells. 2021 Dec 20;10(12):3593. doi: 10.3390/cells10123593.
9
p53 partial loss-of-function mutations sensitize to chemotherapy.p53 部分功能丧失突变使肿瘤对化疗敏感。
Oncogene. 2022 Feb;41(7):1011-1023. doi: 10.1038/s41388-021-02141-5. Epub 2021 Dec 14.
10
Hidden electrostatic energy contributions define dynamic allosteric communications within p53 during molecular recognition.隐藏的静电能量贡献定义了p53在分子识别过程中的动态变构通讯。
Biophys J. 2021 Oct 19;120(20):4512-4524. doi: 10.1016/j.bpj.2021.08.037. Epub 2021 Sep 1.

本文引用的文献

1
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.通过高分辨率错义突变分析理解p53肿瘤抑制蛋白的功能-结构和功能-突变关系。
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. doi: 10.1073/pnas.1431692100. Epub 2003 Jun 25.
2
PUMA mediates the apoptotic response to p53 in colorectal cancer cells.PUMA介导大肠癌细胞对p53的凋亡反应。
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1931-6. doi: 10.1073/pnas.2627984100. Epub 2003 Feb 6.
3
Missense mutations in the DNA-binding region and termination codon in PAX6.PAX6中DNA结合区域的错义突变和终止密码子。
Hum Mutat. 2003 Feb;21(2):138-45. doi: 10.1002/humu.10163.
4
Evolution of gene expression in the Drosophila melanogaster subgroup.黑腹果蝇亚组中基因表达的进化
Nat Genet. 2003 Feb;33(2):138-44. doi: 10.1038/ng1086. Epub 2003 Jan 27.
5
A novel case with germline p53 gene mutation having concurrent multiple primary colon tumours.一例具有种系p53基因突变且并发多个原发性结肠肿瘤的罕见病例。
Gut. 2003 Feb;52(2):304-6. doi: 10.1136/gut.52.2.304.
6
Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.p53转录因子的差异反式激活高度依赖于p53水平和启动子靶序列。
Mol Cell Biol. 2002 Dec;22(24):8612-25. doi: 10.1128/MCB.22.24.8612-8625.2002.
7
Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.具有不同TP53基因剂量的同基因细胞的基因表达谱分析揭示了许多受TP53剂量影响的基因,并将CSPG2鉴定为p53的直接靶点。
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15632-7. doi: 10.1073/pnas.242597299. Epub 2002 Nov 15.
8
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.Prox1是决定淋巴管内皮细胞命运程序中的一个主控基因。
Dev Dyn. 2002 Nov;225(3):351-7. doi: 10.1002/dvdy.10163.
9
Transcription factors as targets for cancer therapy.作为癌症治疗靶点的转录因子。
Nat Rev Cancer. 2002 Oct;2(10):740-9. doi: 10.1038/nrc906.
10
Immunology: the roots of antibody diversity.免疫学:抗体多样性的根源
Nature. 2002 Sep 5;419(6902):29-31. doi: 10.1038/419029a.

序列特异性转录因子p53的功能突变体及其对多样性主控基因的影响。

Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.

作者信息

Resnick Michael A, Inga Alberto

机构信息

Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.

出版信息

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9934-9. doi: 10.1073/pnas.1633803100. Epub 2003 Aug 8.

DOI:10.1073/pnas.1633803100
PMID:12909720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC187891/
Abstract

There are many sources of genetic diversity, ranging from programmed mutagenesis in antibody genes to random mutagenesis during species evolution or development of cancer. We propose that mutations in DNA sequence-specific transcription factors that target response elements (REs) in many genes can also provide for rapid and broad phenotypic diversity, if the mutations lead to altered binding affinities at individual REs. To test this concept, we examined the in vivo transactivation capacity of wild-type human and murine p53 and 25 partial function mutants. The p53s were expressed in yeast from a rheostatable promoter, and the transactivation capacities toward >15 promoter REs upstream of a reporter gene were measured. Surprisingly, there was wide variation in transactivation by the mutant p53s toward the various REs. This is the first study to address directly the impact of mutations in a sequence-specific transcription factor on transactivation from a wide array of REs. We propose a master gene hypothesis for phenotypic diversity where the master gene is a single transcriptional activator (or repressor) that regulates many genes through different REs. Mutations of the master gene can lead to a variety of simultaneous changes in both the selection of targets and the extent of transcriptional modulation at the individual targets, resulting in a vast number of potential phenotypes that can be created with minimal mutational changes without altering existing protein-protein interactions.

摘要

遗传多样性有许多来源,从抗体基因中的程序性诱变到物种进化或癌症发展过程中的随机诱变。我们提出,如果突变导致在单个反应元件(RE)处结合亲和力改变,那么靶向许多基因中反应元件的DNA序列特异性转录因子的突变也能提供快速而广泛的表型多样性。为了验证这一概念,我们检测了野生型人类和小鼠p53以及25个部分功能突变体的体内反式激活能力。p53在酵母中由一个可调启动子表达,并测量了其对报告基因上游>15个启动子RE的反式激活能力。令人惊讶的是,突变型p53对各种RE的反式激活存在广泛差异。这是第一项直接研究序列特异性转录因子中的突变对来自多种RE的反式激活影响的研究。我们提出了一个关于表型多样性的主基因假说,其中主基因是一个单一的转录激活因子(或抑制因子),它通过不同的RE调节许多基因。主基因的突变可导致在靶标的选择以及单个靶标处转录调控程度上同时发生多种变化,从而在不改变现有蛋白质-蛋白质相互作用的情况下,以最少的突变变化产生大量潜在表型。